FindTrial
Sign In

Evaluation of pregnancy outcomes based on immunological marker

Expression of CD200 in pregnant women to analyse the pregnancy outcomes â?? A pilot study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/08/056328
Enrollment
40
Registered
2023-08-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O131- Gestational [pregnancy-induced] hypertension without significant proteinuria, first trimester Health Condition 2: O038- Other and unspecified complications following complete or unspecified spontaneous abortion

Interventions

Intervention1: NIL: NIL

Sponsors

MAHE, Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Single/ multiple pregnancy women and natural conception/conception by assisted reproductive technique with low placental growth factor (PlGF) value.

Exclusion criteria

Exclusion criteria: Women with diseases and under treatment (Hypertension, diabetes mellitus, thyroid disorders, autoimmune disorders, hypercholesterolemia) becomes pregnant. Women are aged >40 or <18 years will be excluded

Design outcomes

Secondary

MeasureTime frame
Scientific evidence for proposing immunomodulator therapyTimepoint: 1 year—

Primary

MeasureTime frame
Establishing the CD200 cut-off value in pregnant women.Timepoint: 1 Year—

Countries

India

Contacts

Public ContactDr Vaideki B

Kasturba Medical College, Manipal, MAHE, Manipal

vaideki.b@manipal.edu9842112419

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026